Retraction: ErHuang formula improves renal fibrosis in diabetic nephropathy rats by inhibiting CXCL6/JAK/STAT3 signaling pathway
Saved in:
| Main Author: | Frontiers Editorial Office |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Pharmacology |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1530375/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Retraction: Corrigendum: ErHuang formula improves renal fibrosis in diabetic nephropathy rats by inhibiting CXCL6/JAK/STAT3 signaling pathway
by: Frontiers Editorial Office
Published: (2024-12-01) -
RETRACTED: Corrigendum: ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway
by: Yu-Li Shen, et al.
Published: (2021-11-01) -
Retraction: CXCL6 promotes renal interstitial fibrosis in diabetic nephropathy by activating JAK/STAT3 signaling pathway
by: Frontiers Editorial Office
Published: (2024-12-01) -
Retraction: Huang Y, et al. Sophocarpine inhibits the growth of gastric cancer cells via autophagy and apoptosis. Frontiers in Bioscience-Landmark. 2019; 24: 616–627
by: Frontiers in Bioscience-Landmark Editorial Office
Published: (2024-11-01) -
Myeloma cell-derived CXCL7 facilitates proliferation of tumor cells and occurrence of osteolytic lesions through JAK/STAT3 pathway
by: Yue Wang, et al.
Published: (2025-02-01)